Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis

Cancer Research

Volumn 71, Issue 8, 2011, Pages 3162-3172

  Li, Xin Jian ^a   Ong, Choon Kiat ^c   Cao, Yun ^a   Xiang, Yan Qun ^b   Shao, Jian Yong ^a   Ooi, Aikseng ^d   Peng, Li Xia ^a   Lu, Wen Hua ^a   Zhang, Zhongfa ^e   Petillo, David ^d   Qin, Li ^a   Bao, Ying Na ^a   Zheng, Fang Jing ^a   Chia, Claramae Shulyn ^c   Iyer, N Gopalakrishna ^c   Kang, Tie Bang ^a   Zeng, Yi Xin ^a   Soo, Khee Chee ^c   Trent, Jeffrey M ^d   Teh, Bin Tean ^c,d   Qian, Chao Nan ^a,b,c,d   more..

^a UNIVERSITY OF SOUTH CHINA   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d VAN ANDEL RESEARCH INSTITUTE   (United States)

^e WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM COMPLEX; PROTEOGLYCAN; SERGLYCIN; UNCLASSIFIED DRUG; VIMENTIN;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CELL CLONE; CELL MOTILITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MOUSE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN GLYCOSYLATION; PROTEIN SECRETION;

ADOLESCENT; ADULT; AGED; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEOGLYCANS; RNA, MESSENGER; VESICULAR TRANSPORT PROTEINS; YOUNG ADULT;

EID: 79954613658     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-3557     Document Type: Article

References (46)

1. Wee JT, Ha TC, Loong SL, Qian CN. Is nasopharyngeal cancer really a "Cantonese cancer"? Chin J Cancer 2010;29:517-26.
2. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:421-9. (Pubitemid 35370755)
3. Ahmad A, Stefani S. Distant metastases of nasopharyngeal carcinoma: A study of 256 male patients. J Surg Oncol 1986;33: 194-7. (Pubitemid 17188823)
4. Geara FB, Sanguineti G, Tucker SL, Garden AS, Ang KK, Morrison WH, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of distant metastasis and survival. Radiother Oncol 1997;43:53-61. (Pubitemid 27191979)
5. Lee AW, Law SC, Foo W, Poon YF, Cheung FK, Chan DK, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: Survival after local recurrence. Int J Radiat Oncol Biol Phys 1993;26:773-82.
6. Guigay J. Advances in nasopharyngeal carcinoma. Curr Opin Oncol 2008;20:264-9.
7. Kolset SO, Zernichow L. Serglycin and secretion in human monocytes. Glycoconj J 2008;25:305-11. (Pubitemid 351432853)
8. Pejler G, Abrink M, Wernersson S. Serglycin proteoglycan: Regulating the storage and activities of hematopoietic proteases. Biofactors 2009;35:61-8.
9. Kolset SO, Tveit H. Serglycin-structure and biology. Cell Mol Life Sci 2008;65:1073-85.
10. Woulfe DS, Lilliendahl JK, August S, Rauova L, Kowalska MA, Abrink M, et al. Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood 2008;111: 3458-67.
11. Toyama-Sorimachi N, Kitamura F, Habuchi H, Tobita Y, Kimata K, Miyasaka M. Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells. J Biol Chem 1997;272:26714-9. (Pubitemid 27458898)
12. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C, et al. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 1999;400:769-72. (Pubitemid 29399538)
13. Duelli A, Ronnberg E, Waern I, Ringvall M, Kolset SO, Pejler G. Mast cell differentiation and activation is closely linked to expression of genes coding for the serglycin proteoglycan core protein and a distinct set of chondroitin sulfate and heparin sulfotransferases. J Immunol 2009;183:7073-83.
14. Schick BP, Gradowski JF, San Antonio JD. Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells. Blood 2001;97:449-58. (Pubitemid 32060330)
15. Toyama-Sorimachi N, Miyasaka M. A sulfated proteoglycan as a novel ligand for CD44. J Dermatol 1994;21:795-801. (Pubitemid 24380661)
16. Toyama-Sorimachi N, Sorimachi H, Tobita Y, Kitamura F, Yagita H, Suzuki K, et al. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. J Biol Chem 1995;270: 7437-44.
17. Uhlin-Hansen L, Wik T, Kjellen L, Berg E, Forsdahl F, Kolset SO. Proteoglycan metabolism in normal and inflammatory human macrophages. Blood 1993;82:2880-9. (Pubitemid 23318097)
18. Winberg JO, Kolset SO, Berg E, Uhlin-Hansen L. Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J Mol Biol 2000;304: 669-80. (Pubitemid 32006198)
19. Zernichow L, Dalen KT, Prydz K, Winberg JO, Kolset SO. Secretion of proteases in serglycin transfected Madin-Darby canine kidney cells. FEBS J 2006;273:536-47.
20. Schick BP, Ho HC, Brodbeck KC, Wrigley CW, Klimas J. Serglycin proteoglycan expression and synthesis in embryonic stem cells. Biochim Biophys Acta 2003;1593:259-67. (Pubitemid 36173494)
21. Elliott JF, Miller CL, Pohajdak B, Talbot D, Helgason CD, Bleackley RC, et al. Induction of a proteoglycan core protein mRNA in mouse T lymphocytes. Mol Immunol 1993;30:749-54.
22. Kulseth MA, Mustorp SL, Uhlin-Hansen L, Oberg F, Kolset SO. Serglycin expression during monocytic differentiation of U937-1 cells. Glycobiology 1998;8:747-53. (Pubitemid 28356846)
23. Maillet P, Alliel PM, Mitjavila MT, Perin JP, Jolles P, Bonnet F. Expression of the serglycin gene in human leukemic cell lines. Leukemia 1992;6:1143-7.
24. Abrink M, Grujic M, Pejler G. Serglycin is essential for maturation of mast cell secretory granule. J Biol Chem 2004;279:40897-905. (Pubitemid 39287689)
25. Braga T, Grujic M, Lukinius A, Hellman L, Abrink M, Pejler G. Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells. Biochem J 2007;403:49-57. (Pubitemid 46569866)
26. Henningsson F, Hergeth S, Cortelius R, Abrink M, Pejler G. A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components. FEBS J 2006;273:4901-12. (Pubitemid 44583514)
27. Ringvall M, Ronnberg E, Wernersson S, Duelli A, Henningsson F, Abrink M, et al. Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan. J Allergy Clin Immunol 2008;121:1020-6.
28. Lieberman J. The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal. Nat Rev Immunol 2003;3:361-70. (Pubitemid 37323196)
29. Veugelers K, Motyka B, Goping IS, Shostak I, Sawchuk T, Bleackley RC. Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate. Mol Biol Cell 2006;17:623-33. (Pubitemid 43191098)
30. Raja SM, Metkar SS, Honing S, Wang B, Russin WA, Pipalia NH, et al. A novel mechanism for protein delivery: Granzyme B undergoes electrostatic exchange from serglycin to target cells. J Biol Chem 2005;280:20752-61. (Pubitemid 40776780)
31. Galvin JP, Spaeny-Dekking LH, Wang B, Seth P, Hack CE, Froelich CJ. Apoptosis induced by granzyme B-glycosaminoglycan complexes: Implications for granule-mediated apoptosis in vivo. J Immunol 1999;162:5345-50. (Pubitemid 29307141)
32. Dressel R, Raja SM, Honing S, Seidler T, Froelich CJ, von Figura K, et al. Granzyme-mediated cytotoxicity does not involve the mannose 6-phosphate receptors on target cells. J Biol Chem 2004;279:20200-10. (Pubitemid 38623465)
33. Metkar SS, Wang B, Aguilar-Santelises M, Raja SM, Uhlin-Hansen L, Podack E, et al. Cytotoxic cell granule-mediated apoptosis: Perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 2002;16:417-28. (Pubitemid 34260919)
34. Raja SM, Wang B, Dantuluri M, Desai UR, Demeler B, Spiegel K, et al. Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J Biol Chem 2002;277:49523-30. (Pubitemid 36014390)
35. Niemann CU, Kjeldsen L, Ralfkiaer E, Jensen MK, Borregaard N. Serglycin proteoglycan in hematologic malignancies: A marker of acute myeloid leukemia. Leukemia 2007;21:2406-10. (Pubitemid 350148881)
36. Theocharis AD, Seidel C, Borset M, Dobra K, Baykov V, Labropoulou V, et al. Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro. J Biol Chem 2006;281:35116-28.
37. Schick BP. Serglycin proteoglycan deletion in mouse platelets physiological effects and their implications for platelet contributions to thrombosis, inflammation, atherosclerosis, and metastasis. Prog Mol Biol Transl Sci; 93:235-87.
38. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90.
39. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
40. Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, et al. Preparing the "soil": The primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res 2006;66:10365-76. (Pubitemid 44799756)
41. Yao X, Qian CN, Zhang ZF, Tan MH, Kort EJ, Yang XJ, et al. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res 2007;13:161-9. (Pubitemid 46121865)
42. Qian CN, Furge KA, Knol J, Huang D, Chen J, Dykema KJ, et al. Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: Identification in human tumors and confirmation in animal models. Cancer Res 2009;69:8256-64.
43. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987;8:138-40.
44. Song LB, Yan J, Jian SW, Zhang L, Li MZ, Li D, et al. [Molecular mechanisms of tumorgenesis and metastasis in nasopharyngeal carcinoma cell sublines]. Ai Zheng 2002;21:158-62.
45. Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med 2008;359:2814-23.
46. Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 2007;313: 2050-62. (Pubitemid 46842979)